SOLID MALIGNANT TUMOR
Clinical trials for SOLID MALIGNANT TUMOR explained in plain language.
Never miss a new study
Get alerted when new SOLID MALIGNANT TUMOR trials appear
Sign up with your email to follow new studies for SOLID MALIGNANT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called JL19001 in people with advanced solid tumors or a type of lymphoma that has come back or not responded to treatment. The main goal is to find a safe dose and check for side effects. About 14 participants will receive the drug as a sh…
Matched conditions: SOLID MALIGNANT TUMOR
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug may shield cancer patients from dangerous infection risk
Prevention Recruiting nowThis real-world study looks at whether a drug called mecapegfilgrastim can prevent neutropenia (a low white blood cell count) in cancer patients after chemotherapy, radiation, or immunotherapy. The study will follow 200 adults with solid tumors who are at high or moderate risk of…
Matched conditions: SOLID MALIGNANT TUMOR
Sponsor: Hebei Medical University Fourth Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
New drug may tame immunotherapy skin rash without steroids
Symptom relief Recruiting nowThis phase II trial tests whether JAK inhibitors can safely and effectively treat severe skin rashes caused by immune checkpoint inhibitors in cancer patients. The goal is to relieve symptoms without using steroids, which can weaken the anti-cancer effect of immunotherapy. The st…
Matched conditions: SOLID MALIGNANT TUMOR
Phase: PHASE2 • Sponsor: Shixiu Wu • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC